发表用PCT-炎症-芯片数据-PLOS.DOC

Table S1 Gene expression alteration in PC3 cells treated with 10 μM RB for 24 h (=1.5-fold) Genes Description PC3/RB (Log ratio) NF-κB related NM_001145138 RELA v-rel reticuloendotheliosis viral oncogene homolog A (avian) -2.11 NM_003998 NFKB1 nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 -3.16 NM_001077493 NFKB2 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) -1.79 NM_006509 RELB v-rel reticuloendotheliosis viral oncogene homolog B -3.25 NM_002908 REL v-rel reticuloendotheliosis viral oncogene homolog (avian) -1.09 Cell cycle and Proliferation NM_031966 CCNB1 cyclin B1 -2.06 NM_004701 CCNB2 cyclin B2 -1.85 NM_053056 CCND1 cyclin D1 -2.32 NM CCND3 cyclin D3 -1.73 NM_001761 CCNF cyclin F -2.32 NM_004354 CCNG2 cyclin G2 1.88 NM_001134375 CCNJ cyclin J -2.10 NM_001798 CDK2 cyclin-dependent kinase 2 -2.52 NM_001145306 CDK6 cyclin-dependent kinase 6 -1.94 NM_001260 CDK8 cyclin-dependent kinase 8 -1.72 NM_001130829 CDC2 cell division cycle 2, G1 to S and G2 to M -3.68 NM_000389 CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 1.75 NM_000076 CDKN1C cyclin-dependent kinase inhibitor 1C (p57, Kip2) 1.80 NM_002592 PCNA proliferating cell nuclear antigen -3.71 Invasion and Metastasis NM_001025366 VEGFA vascular endothelial growth factor A 2.45 NM_005429 VEGFC vascular endothelial growth factor C -1.74 NM_001145031 PLAU plasminogen activator, urokinase -7.38 NM_001005376 PLAUR plasminogen activator, urokinase receptor -3.09 Adhesion NM_000610 CD44 CD44 molecule (Indian blood group) -2.32 NM_002203 ITGA2 integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) -1.91 NM_002205 ITGA5 integrin, alpha 5 (fibronectin receptor, alpha polypeptide) -1.63 NM_000210 ITGA6 integrin, alpha 6 -3.23 NM_000201